Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Immunoblastic sarcoma: a clinical description.

A Lichtenstein, A M Levine, R J Lukes

|January 1, 1979

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Retraction Note: Therapeutic potential of targeting IRES-dependent c-myc translation in multiple myeloma cells during ER stress.

Oncogene·2023

Same author

Editorial Expression of Concern: MNK kinases facilitate c-myc IRES activity in rapamycin-treated multiple myeloma cells.

Oncogene·2023

Same author

Fatty acids and osteoarthritis: the MOST study.

Osteoarthritis and cartilage·2021

Same author

Local magnetic moments in iron and nickel at ambient and Earth's core conditions.

Nature communications·2017

Same author

Lactobacillus johnsonii supplementation attenuates respiratory viral infection via metabolic reprogramming and immune cell modulation.

Mucosal immunology·2017

Same author

The Medical Bookshelf.

Postgraduate medicine·2016

Same journal

Toward exercise as standard care for older cancer survivors.

Cancer·2026

Same journal

Maintenance therapy in gynecologic malignancies: Current and future state.

Cancer·2026

Same journal

Long-term outcomes of evolving treatment regimens in Ewing sarcoma survivors diagnosed 1970-1999: A report from the Childhood Cancer Survivor Study.

Cancer·2026

Same journal

Large-scale osteosarcoma sequencing reveals age-associated genomic architectures.

Cancer·2026

Same journal

EZH2 inhibitor tazemetostat voluntarily withdrawn from market.

Cancer·2026

Same journal

Nivolumab and chemotherapy combination approved for previously untreated Hodgkin lymphoma.

Cancer·2026

See all related articles

Immunoblastic Sarcoma (IBS) often presents with prior immune disease or lymphoproliferative malignancy. Key clinical features include anemia, lymphopenia, and advanced stage, which are associated with poorer survival outcomes.

Area of Science:

Oncology
Hematology
Immunology

Background:

Immunoblastic Sarcoma (IBS) is a distinct clinicopathological entity.
Understanding its clinical presentation and prognostic factors is crucial for patient management.

Purpose of the Study:

To clinically characterize Immunoblastic Sarcoma.
To identify common features and prognostic indicators in IBS patients.

Main Methods:

Retrospective review of clinical records from 33 patients diagnosed with Immunoblastic Sarcoma.
Analysis of clinical presentation, laboratory findings, disease stage, and survival data.

Main Results:

30% of patients had a history of immune disease or lymphoproliferative malignancy.

Related Experiment Videos

Common findings included diffuse hypergammaglobulinemia (44%), lymphopenia (45%), and anemia (73%).

70% of patients presented with advanced stage (III or IV), and 49% had systemic symptoms; both were linked to decreased survival (p < .05). Median survival was 14 months.

Conclusions:

Immunoblastic Sarcoma is a clinical entity frequently associated with a history of immune disorders or diffuse hypergammaglobulinemia.
Advanced stage, lymphopenia, and systemic symptoms are significant negative prognostic factors in IBS.
Further research into the pathogenesis and treatment of IBS is warranted.